Trials / Completed
CompletedNCT02695004
Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).
Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Phase 1 Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics of DKF-310 Intramuscular Injection in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Dongkook Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This is a study to evaluate safety, tolerability and PK of DKF-310 IM injection in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DKF-310 | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2017-03-01
- Completion
- 2017-03-01
- First posted
- 2016-03-01
- Last updated
- 2020-04-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02695004. Inclusion in this directory is not an endorsement.